Excellent outcome in infants and small children with thrombophilias undergoing kidney transplantation

Andre A Dick1, Susan M Lerner, Adrienne R Boissy

  • 1Department of Surgery, Penn State University, Hershey, PA 17033, USA.

Pediatric Transplantation
|January 26, 2005
PubMed

Insights

Pediatric renal transplant recipients with thrombophilia, such as protein C, protein S, and factor V Leiden deficiencies, face a high risk of graft thrombosis. Early diagnosis and peri-operative anticoagulation can prevent adverse outcomes in these young patients.

Area of Science:

  • Pediatric Nephrology
  • Transplantation Immunology
  • Hematology

Background:

  • Vascular thrombosis is a leading cause of early graft loss in pediatric renal transplantation.
  • Thrombophilias, including protein C, protein S, and factor V Leiden deficiencies, are known risk factors for thrombosis.
  • Limited data exists on the outcomes of renal transplantation in infants and small children with thrombophilias.

Purpose of the Study:

  • To review the institution's experience with the diagnosis, peri-operative management, and follow-up of pediatric renal transplant recipients with thrombophilias.
  • To assess the incidence of graft thrombosis in this high-risk population.
  • To identify strategies for improving outcomes in infants and small children undergoing renal transplantation with thrombophilia.

Main Methods:

  • Retrospective analysis of pediatric renal transplant recipients from May 2000 onwards.
  • Data collected from the institution's Pediatric Transplant Registry.
  • Identification of patients with thrombophilias (factor V Leiden mutation, protein S deficiency) and review of their management and outcomes.

Main Results:

  • Three pediatric patients with thrombophilias (one factor V Leiden, two protein S deficiency) underwent renal transplantation.
  • All transplants were from living donors and patients received peri-operative anticoagulation.
  • No adverse outcomes or graft thrombosis were observed in children with thrombophilias, despite lower mean weight compared to controls.

Conclusions:

  • Thrombophilia is a significant, potentially under-recognized cause of graft thrombosis in pediatric renal transplant recipients.
  • A high index of suspicion, preoperative screening for thrombophilias, and appropriate anticoagulation management are crucial.
  • These strategies may reduce the incidence of graft thrombosis in infants and small children undergoing renal transplantation.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...